M ovement disorders are common, and can be difficult to categorise correctly. In this article, we present the common movement disorders seen by GPs and provide an overview of their classification. Most movement disorders presenting in primary care will need referral to a neurologist for full diagnosis and management. However, essential tremor is usually managed in primary care, and being able to differentiate it from other forms of tremor, especially Parkinson's disease, as well as being familiar with its initial management, is important. For all patients, being aware of the potential impact on daily function is paramount, and adopting a multidisciplinary approach to management should always be considered.
The GP curriculum and movement disorders Movement disorders are listed as a common and important condition forming part of the knowledge-based clinical example 3.18: Care of people with neurological problems. GPs should be able to: . Manage primary contact with patients who have a movement disorder . Demonstrate a reasoned approach to the diagnosis of abnormal movements and tremor using history and examination . Knowledge of secondary care investigations and treatment . Understand the principles of treatment for common conditions managed largely in primary care such as essential tremor and Parkinson's disease . Describe the indications for referral to a neurologist for chronic conditions requiring ongoing specialist management (e.g. Parkinson's disease 
Tremor
Tremor occurs when there is an involuntary movement of a body part, usually the hands and arms, which has a rhythmic quality. The differential diagnosis is quite wide but in general practice, the common causes are essential tremor (ET), parkinsonism, cerebellar disease and enhanced physiological tremor (Table 1) . Table 2 shows the different types of tremor and their characteristics. In all cases, unless the tremor is clearly ET, specialist referral to a neurologist is needed to establish a diagnosis and for advice on further management. ......................................................................................................................................................................................................... contraction of opposing muscle groups, leading to painful abnormal posturing, and writhing movements. Athetosis is an older term (which is now thought to be part of the spectrum of dystonia) where the affected body part undergoes writhing movements, and the patient is unable to keep it in one position.
Increased
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Aetiologically, dystonia may be primary or secondary. Primary dystonias are usually dominantly inherited (although a few are sporadic or inherited in a different manner). Secondary dystonia occurs as a part of an underlying, often neurodegenerative, disorder, such as Huntington's disease or Wilson's disease, but may also be due to basal ganglia insult (commonly stroke, infection or tumours), or drugs (especially dopamine agonists).
Dystonia may also be categorised by its distribution, with focal dystonia affecting one muscle group, segmental dystonia affecting two adjacent muscle groups and generalised dystonia affecting most of the body. In general practice, focal and segmental dystonias are the most commonly seen forms ( Table 3) .
Investigation of dystonia is carried out by a neurologist, and usually involves magnetic resonance imaging (MRI) of the brain as well as specific testing for common causes of secondary dystonia such as Wilson's disease. Management is multidisciplinary, and often involves physiotherapy, occupational therapy, speech and language therapy, and psychiatry. Medical treatment is . with a combination of benzodiazepines, antispasmodics, anti-convulsants and anti-parkinsonian drugs.
The use of botulinum toxin injections has revolutionised the treatment of many focal and segmental dystonias, providing relief from symptoms for up to 4 months. Surgical options include deep brain stimulation or surgery to the affected muscles, but are only considered in very severe or refractory dystonias.
Chorea
Chorea is a sudden jerky involuntary movement that is random in distribution, non-rhythmic and non-sustained. It can affect any part of the body, and is usually bilateral. The most common cause is Huntington's disease (HD), but it can also be due to other conditions (Box 1).
Chorea may manifest alone or in combination with another movement disorder, frequently athetoid dystonia. This leads to jerky, writhing movements known as choreoathetosis, and is commonly seen in HD.
A patient presenting with choreiform movements must be referred to a neurologist with a special interest in movement disorders for further investigation. The crux of the specialist investigative pathway is a detailed family history for evidence of HD. In atypical cases, or in the absence of a positive family history, genetic testing is required. Important blood tests include thyroid function, autoimmune screen and serum caeruloplasmin. Brain imaging with MRI is usually preformed to look for structural causes.
Management is dependent on the underlying disease. For drug-induced chorea, adjusting doses or stopping the drug completely may be all that is required. Dopaminedepleting drugs such as haloperidol can help with chorea.
Ballismus
Dramatic sudden flinging movements, mainly affecting the limbs, are known as ballismus. If limited to one side of the body, this is called hemiballismus. This is seen more commonly than ballismus, although it is still very rare. The most common cause of hemiballismus is a stroke.
Myoclonus
Myoclonus is a brief non-sustained electric-shock-like movement that occurs due to involuntary muscle contraction. This may be physiological (e.g. hiccoughs, hypnic jerks during sleep), due to certain drugs (especially selective serotonin reuptake inhibitor antidepressants and morphine), or seen in certain conditions such as epilepsy and prion disease.
Asterixis
Also known as negative myoclonus, asterexis describes sudden involuntary relaxation of a contracted muscle. The common causes in clinical practice are carbon dioxide retention (e.g. type 2 respiratory failure in chronic obstructive pulmonary disease, and encephalopathy of liver disease. 
Tics
Tics are brief, intermittent, meaningless movements (motor tics) or sounds (phonic tics), preceded by premonitory urges. They can be willfully suppressed and often disappear with distraction, suggesting that they may be semi-voluntary. Premonitory urges, are unpleasant sensations which are relieved by carrying out the tic.
There are three main tic disorders, characterised by frequent tics starting before the age of 18. Transient tic disorder is characterised by motor and/or phonic tics which last between 1 and 12 months. Chronic tic disorder has motor or phonic tics which last more than 1 year. Gilles de la Tourette Syndrome has motor and phonic tics which last more than 1 year.
Management is usually with education and reassurance that most tics will resolve spontaneously. If they interfere with daily activity, then cognitive behavioural therapy and habit reversal training has been shown to be effective. Drug treatment includes antipsychotics and clonidine, but must be supervised by a specialist. Specialist referral for botulinum toxin injections or for deep brain stimulation (DBS) may be considered in very severe cases that have not responded to conventional therapy. For some patients, pharmacological tremor control is only needed on an as required (prn) basis. This may, for instance, be prior to an important occasion or an activity that normally provokes tremor. In this situation propranolol is the drug of choice and should be taken approximately an hour prior to the event, as a single dose (usually 20-80 mg). Alcohol also has a good effect on reducing tremor and some patients may use it in a similar manner but should be discouraged from excessive consumption.
For patients who have more severe symptoms, chronic tremor suppression therapy with either regular propranolol or primidone should be initiated. Both are equally effective in chronic tremor suppression and can show a significant benefit in up to 75% of patients. The choice of which medication to use first is arbitrary. Some neurologists advocate the use of propranolol as first line in younger patients, while choosing primidone as a first line in older patients, but this is not universal practice.
In both cases, the drug should be started at a low dose, and then titrated up according to response, as well as tolerance. This is especially important with primidone, where there is a possibility of a severe acute allergic reaction. Because of this, some GPs feel more comfortable using propranolol in the first instance, and refer to a specialist if primidone is thought to be necessary.
For propranolol, the usual starting dose is 10-60 mg per day either as divided doses or a once daily sustained release preparation. Often a daily dose of 120 mg is enough to show a significant benefit, although some patients may require as much as 320 mg per day. The important side effects that patients may experience with propranolol are: . Hypotension . Bradycardia . Peripheral vasoconstriction . Bronchospasm . Gastrointestinal symptoms . Impotence
It is important to monitor blood pressure and heart rate, and advise patients not to stop propranolol abruptly due to potential rebound hypertension. Anyone with asthma, bradycardia or hypotension should not be prescribed propranolol.
Primidone ( , and should be started at a very low dose, usually 12.5 mg (note that primidone comes in 50 and 250 mg preparations, so initiation and titration will require cutting tablets into quarters). Titration is much slower than with propranolol, and usually takes months, increasing the night time dose by 12.5 mg every week. In most cases, the maximum dose required is 250 mg nocte (although under the care of a specialist, this can be increased to as much as 750 mg nocte). Adverse effects are relatively common (usually nausea, vomiting, sedation and ataxia), but are usually mild, and improve within a few days of continued treatment.
In cases where patients do not improve with maximal recommended dosage, consider referral for specialist care. Specialist options include off-licence higher doses of primidone, combination therapy with propranolol and primidone or non-pharmocological treatment options, such as intramuscular botulinum toxin, stereotactic thalamic surgery, or deep brain stimulation.
Parkinson's disease PD is one of the most common neurological conditions affecting older people. It is characterised by loss of pigmented neurons in the substantia nigra of the basal ganglia, and the presence of alpha-synuclein containing Lewy bodies. Motor PD symptoms typically manifest after 60% of the pigmented neurons have been lost. In addition to akinesia and rigidity, patients also have tremor and postural problems (Table 5) .
Presentation is usually asymmetric, and may initially be unilateral, differentiating it from other causes of parkinsonism. As the disease progresses, functional ability reduces, eventually leading to the patient becoming fully dependent. Life expectancy is reduced, mainly through a tendency to falling, venous thromboembolism and respiratory tract infections.
If the presentation is typical, diagnosis can be made clinically but patients should always be referred for specialist confirmation of the diagnosis and initiation of treatment through a specialist PD clinic.
A multidisciplinary approach is vital. In early PD, often no pharmacological treatment is necessary, as the symptoms may not affect normal functioning, and the side effects of treatment may be quite significant. When the disease progresses sufficiently such that it adversely affects activities of daily living, it is usual to start pharmacological treatment.
The different options available are summarised in Table 6 . Treatment is usually initiated by a neurologist or a physician with an interest in PD. Once the patient is stable, maintenance of therapy and ongoing care is often via the GP.
L-dopa with a dopa-decarboxilase inhibitor, is the most commonly used initial treatment. If patients develop L-dopa induced dyskinesia (LID) , then the dosage of L-dopa can be reduced and a dopamine agonist added.
As the disease progresses to that of almost complete akinesia, the patient may fluctuate between being mobile with dyskinesia (when the effect of L-dopa is active) and immobile and akinetic (when the L-dopa wears off). This is known as the on/off phenomenon. Patients who have on/off phenomenon may benefit from dopamine agonists (especially subcutaneous apomorphine) during the off periods.
Differentiating LID from the movement disorder of PD itself can be difficult. In general, LID commonly includes choreiform and dystonic movements, and tends to . ......................................................................................................................................................................................................... manifest earliest in the side that is worst affected, and frequently affects the lower limbs before the upper limbs (whereas PD tends to affect the upper limbs before the lower limbs). PD and its treatment was discussed in detail in a previous InnovAiT article.
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Drug-induced parkinsonism
This accounts for about 10% of cases of parkinsonism. Box 2 lists the common causative drugs. These drugs either deplete dopamine or block its receptors.
There tends to be a more rapid progression of symptoms, compared with PD, often with bilateral involvement from the start. Management involves stopping the drug. Sometimes, anticholinergic drugs can help.
Parkinson plus syndromes
Parkinson plus syndromes account for about 5% of causes of parkinsonism. The name refers to the presence of additional features that are not found in PD. The conditions included in this category are multiple system atrophy (MSA), progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). Table 7 lists the different features of these conditions. Whenever a patient presents with Parkinsonian features, deliberate care must be taken to look specifically for the additional features pointing towards a Parkinson plus syndrome, as treatment with L-dopa is often not as effective as in PD.
Huntington's disease HD is an autosomal dominant neurodegenerative condition, characterised by a triad of movement disorder (mainly chorea), dementia and behavioural change (Table 8) . Unfortunately, there is no cure, and death within 20 years of diagnosis (usually by the age of 50-60) is almost inevitable.
If there is a positive family history and the features are typical, then further investigation is not required. In the absence of family history, genetic testing is required. In confirmed cases of HD, genetic testing is offered to firstdegree relatives.
Management is symptomatic. Chorea may be treated with drugs, but any treatment must be weighed against potential adverse effects. Anti-dopaminergic drugs, such as tetrabenazine, and benzodiazepines may help. If 
Wilson's disease
Wilson's disease (WD) is an autosomal recessive inherited disorder characterised by the excess deposition of copper in the body. The most common manifestations are liver disease and neuropsychiatric symptoms (see Table 9 ). Most patients have Kayser-Fleischer (KF) rings (deposition of copper in the descemet membrane at the corneo-scleral junction). Other manifestations may include cardiomyopathy and large joint arthropathy.
The presence of KF rings in the context of hepatic dysfunction and neuropsychiatric symptoms is highly suggestive. Copper investigations show low serum caeruloplasmin and high 24-hour urinary copper. If there is doubt, liver biopsy is diagnostic. Genetic testing can also be performed.
Reducing body copper can be achieved by:
. D-penicillamine: this is a copper chelating agent that increases urinary copper excretion. If patients are intolerant, then trientine can be used as second line . Zinc acetate reduces intestinal copper absorption
Key points
. Movement disorders can be classified into those that cause increased movement, and those that lead to reduced movement . ET is a common cause of tremor, and is often misdiagnosed as PD . . Dystonia is characterised by sustained abnormal movements, unlike most other movement disorders . PD accounts for 80% of the akinetic/rigid syndromes, and features a combination of akinesia, rigidity, tremor and postural instability . One must look specifically for features of a Parkinson plus syndrome in any patient with signs of parkinsonism . The typical triad of HD includes movement disorder, dementia and behavioural change
